Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05270889 | Study to Evaluate the Safety and Efficacy of Tislelizumab in Combination With Zanidatamab as a 2nd Line in HER2-Positive Advanced Gastric Cancer in K-Umbrella Trial | unknown | Phase 2 | 50 | Yonsei UniversityOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT05141747 | A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer. | unknown | Phase 2 | 60 | Shanghai Miracogen Inc.INDUSTRY | 1 | Feb 23, 2022 |
| clinicaltrials |
| NCT04808466 | Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy(WUHIPEC01) | unknown | Phase 2 | 231 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 21, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT02970539 | Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers | unknown | Phase 1 | 36 | Athenex, Inc.INDUSTRY | 2 | Feb 16, 2022 | clinicaltrials |
| NCT05241899 | A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer | unknown | Phase 2 | 56 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT01889303 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | unknown | Phase 2 | 100 | Wuhan UniversityOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT05228743 | Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer | unknown | N/A | 180 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT05227378 | Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer | unknown | N/A | 36 | Shen LinOTHER | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05221775 | Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients | unknown | Phase 1 | 18 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 3, 2022 | clinicaltrials |
| NCT03939962 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | unknown | Phase 2 | 60 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 26, 2022 | clinicaltrials |
| NCT04062058 | A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer | unknown | Phase 2 | 82 | Jing Jin, M.D.UNKNOWN | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05203549 | Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer | unknown | — | 250 | D1 Medical Technology (Shanghai) Co., Ltd, ChinaINDUSTRY | 1 | Jan 24, 2022 | clinicaltrials |
| NCT05204173 | Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis | unknown | Phase 2 | 30 | Ruijin HospitalOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT04782791 | Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer | unknown | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 0 | Jan 11, 2022 | clinicaltrials |
| NCT05184946 | Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma | unknown | Phase 2 | 72 | The Second Affiliated Hospital of Shandong First Medical UniversityOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT03801668 | Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma | unknown | Phase 3 | 294 | Huazhong University of Science and TechnologyOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT04593134 | Effectiveness of Exercise Program in Improving Quality of Life in Patients With Gastric Cancer Undergoing Gastrectomy | unknown | N/A | 160 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 21, 2021 | clinicaltrials |
| NCT05165602 | Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System | unknown | — | 30 | Peking UniversityOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT02915432 | The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC | unknown | Phase 1 / Phase 2 | 401 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Dec 13, 2021 | clinicaltrials |
| NCT04443478 | Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer | unknown | — | 1,036 | Peking UniversityOTHER | 1 | Dec 2, 2021 | clinicaltrials |
| NCT05113459 | Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018） | unknown | Phase 2 | 40 | Guoxin LiOTHER | 0 | Nov 9, 2021 | clinicaltrials |
| NCT05100446 | Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection | unknown | Early Phase 1 | 100 | Unidade Local de Saúde do Alto Ave, EPEOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT04740346 | Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP) | unknown | N/A | 886 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 27, 2021 | clinicaltrials |
| NCT05095636 | Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer | unknown | Phase 2 | 102 | Fudan UniversityOTHER | 1 | Oct 27, 2021 | clinicaltrials |
| NCT05009966 | Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor | unknown | Phase 1 | 272 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05071755 | Gastrectomy Outcomes in Elderly Patients(GOE) | unknown | — | 350 | Marmara UniversityOTHER | 1 | Oct 19, 2021 | clinicaltrials |
| NCT05070598 | Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer | unknown | Phase 2 | 35 | Shengjing HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT04006821 | PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma | unknown | Phase 2 | 30 | China Medical University, ChinaOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT05051423 | "Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES)(THERRES) | unknown | — | 40 | University of Medicine and Pharmacy CraiovaOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT04607057 | Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient(SUPPORT) | unknown | Phase 4 | 224 | Seoul National University HospitalOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT04434963 | Safety and Feasibility of Reversible Induction Strategy | unknown | — | 20 | RenJi HospitalOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT05039333 | Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation | unknown | — | 36 | Hutom CorpINDUSTRY | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04982939 | Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer | unknown | Phase 2 | 210 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT05029453 | Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy | unknown | Phase 4 | 60 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT04526470 | Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer | unknown | Phase 1 / Phase 2 | 55 | Seoul National University Bundang HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT05002686 | Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis | unknown | Phase 2 / Phase 3 | 60 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT04890392 | Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC | unknown | Phase 2 | 20 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 12, 2021 | clinicaltrials |
| NCT03079596 | ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy and Proximal Gastrectomy | unknown | N/A | 100 | Seoul National University Bundang HospitalOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT05000554 | The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer | unknown | Phase 2 | 30 | The First Hospital of Jilin UniversityOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04993378 | Prospectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy | unknown | — | 40 | Shen LinOTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT04989153 | Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer | unknown | — | 5,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT04980950 | "The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients" | unknown | N/A | 80 | Medical University of GdanskOTHER | 0 | Jul 30, 2021 | clinicaltrials |
| NCT04973475 | Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer | unknown | Phase 2 | 180 | Fujian Medical UniversityOTHER | 1 | Jul 22, 2021 | clinicaltrials |
| NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | unknown | Phase 3 | 388 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jul 19, 2021 | clinicaltrials |
| NCT04957407 | The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning | unknown | — | 5,000 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 12, 2021 | clinicaltrials |
| NCT04947995 | Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer(MONITOR- GAC) | unknown | — | 450 | GeneCast Biotechnology Co., Ltd.INDUSTRY | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04948125 | Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma | unknown | Phase 2 | 20 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04934618 | A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 85 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jun 22, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Mar 8, 2022source: clinicaltrials